J Clin Psychiatry. 2020 May 12;81(3):OT19037BR4. doi: 10.4088/JCP.OT19037BR4.
When a patient with major depressive disorder experiences inadequate response to an antidepressant, clinicians should employ measurement-based care strategies to improve outcomes. Evidence suggests that adjunctive therapies, such as the FDA-approved atypical antipsychotics, are efficacious when the initial treatment is well tolerated but not improving symptoms. Clinicians should consult guidelines, peer-reviewed journals, CME programs, and other sources to stay up-to-date with current and emerging treatments in this area. They should also be familiar with the available options for psychotherapy, neurostimulation, supplements, and exercise for patients who prefer alternative therapies. .
当患有重度抑郁症的患者对抗抑郁药反应不足时,临床医生应采用基于测量的护理策略来改善治疗效果。有证据表明,在初始治疗耐受良好但症状无改善时,辅助治疗(如经 FDA 批准的非典型抗精神病药)是有效的。临床医生应参考指南、同行评议的期刊、CME 项目和其他资源,及时了解该领域当前和新兴的治疗方法。他们还应熟悉对替代疗法有偏好的患者的心理治疗、神经刺激、补充剂和锻炼等可选方案。